Mannheimia haemolytica (Newsom and Cross) Angen et al. (ATCC® 31612)

Strain Designations: 76-72H (Vaccine)  /  Type Strain: no  /  Biosafety Level: 2

Permits And Restrictions

View Permits

Deposited As Pasteurella haemolytica Newsom and Cross
Strain Designations 76-72H (Vaccine)
Application
Used to produce vaccine against Pasteurella haemolytica
Isolation
Derived from existing strain
Type Strain no
Biosafety Level 2
Product Format freeze-dried
Preceptrol® no
Type Strain no
Medium ATCC® Medium 1206: Tryptose broth with thiamine
Growth Conditions
Temperature: 37.0°C
Name of Depositor Norden Labs.
Isolation
Derived from existing strain
References

Kucera CJ. Modified Pasteurella bacteria and vaccines prepared therefrom. US Patent 4,388,299 dated Jun 14 1983

Kucera CJ. Modified Pasteurella haemolytica bacteria. US Patent 4,506,017 dated Mar 19 1985

Kucera CJ. Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom. US Patent 4,626,430 dated Dec 2 1986

derived from ATCC 31611

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation